Action 300725 PHARMABLOCK SCIENCES (NANJING), INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues PharmaBlock Sciences (Nanjing), Inc.

Actions

300725

CNE1000035K5

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 19/06/2024 		Varia. 5j. Varia. 1 janv.
29,06 CNY -1,39% Graphique intraday de PharmaBlock Sciences (Nanjing), Inc. -5,19% -26,00%
23/04 PharmaBlock Sciences (Nanjing), Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
2023 PharmaBlock Sciences (Nanjing), Inc. ouvre une installation HPAPI GMP sur le site de fabrication de Zhejiang CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
PharmaBlock Sciences, Inc. Announces Dividend on Share A for the Year 2023, Payable on June 14, 2024
PharmaBlock Sciences, Inc. Approves Cash Dividend for the Year 2023
PharmaBlock Proposes Final Dividend for 2023
PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.
Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.
Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.
PharmaBlock Sciences, Inc Opens HPAPI GMP Facility at Zhejiang Manufacturing Site
PharmaBlock Sciences, Inc.(SZSE:300725) dropped from Shenzhen Stock Exchange Component A Share Index
PharmaBlock Sciences, Inc.(SZSE:300725) dropped from Shenzhen Stock Exchange Component Index
PharmaBlock Sciences, Inc. announces an Equity Buyback for CNY 40 million worth of its shares.
PharmaBlock Sciences, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
PharmaBlock Sciences, Inc. authorizes a Buyback Plan.
PharmaBlock Sciences, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Pharmablock Sciences, Inc. Announces Final Dividend on Share A for 2022, Payable in June 13, 2023
Pharmablock Sciences, Inc. Approves Election of Jie Yuanping and Wu Juanjuan as Non-Independent Directors
Pharmablock Sciences, Inc. Approves Final Cash Dividend for the Year 2022
PharmaBlock Sciences, Inc. Proposes Final Cash Dividend for the Year 2022
PharmaBlock Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
PharmaBlock Opens New R&D Facility in Pennsylvania
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300725
  4. Actualités PharmaBlock Sciences (Nanjing), Inc.
  5. Autres langues